乳酸脱氢酶/白蛋白比值和单核细胞/淋巴细胞比值与创伤相关ARDS患者病情以及预后的相关性分析

罗丹, 胡强. 乳酸脱氢酶/白蛋白比值和单核细胞/淋巴细胞比值与创伤相关ARDS患者病情以及预后的相关性分析[J]. 临床急诊杂志, 2023, 24(10): 539-543. doi: 10.13201/j.issn.1009-5918.2023.10.008
引用本文: 罗丹, 胡强. 乳酸脱氢酶/白蛋白比值和单核细胞/淋巴细胞比值与创伤相关ARDS患者病情以及预后的相关性分析[J]. 临床急诊杂志, 2023, 24(10): 539-543. doi: 10.13201/j.issn.1009-5918.2023.10.008
LUO Dan, HU Qiang. Correlation analysis of lactate dehydrogenase/albumin ratio, monocyte/lymphocyte ratio with disease and prognosis of trauma-related ARDS patients[J]. J Clin Emerg, 2023, 24(10): 539-543. doi: 10.13201/j.issn.1009-5918.2023.10.008
Citation: LUO Dan, HU Qiang. Correlation analysis of lactate dehydrogenase/albumin ratio, monocyte/lymphocyte ratio with disease and prognosis of trauma-related ARDS patients[J]. J Clin Emerg, 2023, 24(10): 539-543. doi: 10.13201/j.issn.1009-5918.2023.10.008

乳酸脱氢酶/白蛋白比值和单核细胞/淋巴细胞比值与创伤相关ARDS患者病情以及预后的相关性分析

  • 基金项目:
    急救与创伤研究教育部重点实验室开放基金资助项目(No:KLET-202208)
详细信息

Correlation analysis of lactate dehydrogenase/albumin ratio, monocyte/lymphocyte ratio with disease and prognosis of trauma-related ARDS patients

More Information
  • 目的 探讨乳酸脱氢酶/白蛋白比值(lactate dehydrogenase/albumin ratio,LAR)、单核细胞/淋巴细胞比值(monocyte/lymphocyte ratio,MLR)与创伤相关急性呼吸窘迫综合征(acute respiratory distress syndrome, ARDS)患者病情以及预后的关系。方法 回顾性选取2020年2月—2023年2月我院收治的150例创伤相关ARDS患者,根据氧合指数(oxygenation index, OI)分为轻度组(51例)、中度组(63例)、重度组(36例),收集临床和实验室资料,计算LAR、MLR,统计住院28 d内ARDS组患者存活情况。分析影响创伤相关ARDS预后的因素以及LAR、MLR预测创伤相关ARDS预后的价值。结果 ARDS组LAR和MLR高于对照组(P<0.05),重度组LAR和MLR高于中度组和轻度组(P<0.05)。多因素logistic回归分析显示高APACHE Ⅱ评分、重度ARDS、高LAR、MLR是创伤相关ARDS患者预后不良的危险因素(P<0.05)。联合LAR和MLR预测创伤相关ARDS患者预后的曲线下面积为0.920,高于LAR、MLR的0.843、0.818(Z=2.035、2.537,P<0.05)。结论 高LAR和MLR与创伤相关ARDS病情加重以及预后不良有关。
  • 加载中
  • 图 1  LAR、MLR预测创伤相关ARDS患者预后的ROC图

    表 1  不同病情严重程度分组LAR、MLR比较 X±S

    组别 例数 LDH/(U/L) ALB/(g/L) LAR 单核细胞计数/(×109/L) 淋巴细胞计数/(×109/L) MLR
    轻度组 51 379.51±9.32 28.12±1.23 13.50±1.02 1.72±0.13 1.80±0.05 0.96±0.08
    中度组 63 436.29±12.691) 30.65±2.031) 14.23±1.151) 2.06±0.331) 2.06±0.121) 1.00±0.101)
    重度组 36 470.31±14.121)2) 32.15±1.191)2) 14.63±0.911)2) 2.33±0.061)2) 2.22±0.051)2) 1.05±0.131)2)
    F 32.652 42.659 15.956 20.491 22.157 19.428
    P <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
    与轻度组比较,1)P<0.05;与中度组比较,2)P<0.05。
    下载: 导出CSV

    表 2  影响创伤相关ARDS患者预后的单因素 X±S

    因素 死亡组(62例) 存活组(88例) t/χ2 P
    年龄/岁 48.15±10.29 45.09±8.17 2.027 0.044
    性别/例(%) 0.055 0.814
      男 39(62.90) 57(64.77)
      女 23(37.10) 31(35.23)
    创伤类型/例(%) 0.081 0.994
      车祸 22(35.48) 33(37.50)
      跌打伤 17(27.42) 23(26.14)
      割伤 9(14.52) 13(14.77)
      挫伤 14(22.58) 19(21.59)
    ISS评分/分 17.32±3.11 16.53±2.21 1.819 0.071
    GOS评分/分 9.21±2.01 9.03±1.86 0.564 0.573
    APACHE Ⅱ评分/分 16.32±3.06 13.09±2.37 7.280 <0.001
    SOFA评分/分 12.15±2.15 11.79±2.06 1.035 0.303
    心率/(次/min) 79.35±6.29 78.04±6.11 1.277 0.204
    收缩压/mmHg 129.35±11.27 130.04±11.36 0.368 0.714
    舒张压/mmHg 77.04±6.59 77.12±7.32 0.069 0.945
    ARDS严重程度/例(%) 7.820 0.020
      轻度 19(30.65) 32(36.36)
      中度 21(33.87) 42(47.73)
      重度 22(35.48) 14(15.91)
    LDH/(U/L) 439.65±51.31 414.93±42.19 3.229 0.002
    ALB/(g/L) 28.65±2.04 31.21±1.97 7.723 <0.001
    LAR 14.91±2.02 13.53±2.15 3.968 <0.001
    BUN/(mmol/L) 6.32±2.18 6.19±2.05 0.373 0.710
    Scr/(μmol/L) 106.24±11.72 105.21±10.69 0.558 0.578
    单核细胞计数/(×109/L) 2.19±0.23 1.88±0.20 8.783 <0.001
    淋巴细胞计数/(×109/L) 1.93±0.19 2.07±0.23 3.938 <0.001
    MLR 1.13±0.11 0.91±0.14 10.327 <0.001
    白细胞计数/(×109/L) 12.15±2.06 12.03±2.11 0.347 0.730
    是否使用机械通气/例(%) 0.530 0.467
      是 43(69.35) 56(63.64)
      否 19(30.65) 32(36.36)
    是否使用血管加压药/例(%) 11.409 0.001
      是 33(53.23) 23(26.14)
      否 29(46.77) 65(73.86)
    下载: 导出CSV

    表 3  影响创伤相关ARDS患者预后的logistic回归方程

    因素 β SE Wald χ2 OR(95%CI) P
    常数项 10.426 3.195 10.649 - <0.001
    APACHE Ⅱ评分 0.652 0.274 5.662 1.919(1.122~3.284) 0.012
    ARDS病情 1.152 0.412 7.818 3.165(1.411~7.096) 0.002
    LAR 0.701 0.298 5.534 2.016(1.124~3.615) 0.018
    MLR 0.502 0.156 10.355 1.652(1.217~2.243) <0.001
    下载: 导出CSV

    表 4  LAR、MLR预测创伤相关ARDS患者预后的效能

    因素 曲线下面积(95%CI) 临界值 灵敏度/% 特异度/% 约登指数
    LDH 0.629(0.546~0.706) 425.13 U/L 33.87 44.32 -0.218 1
    ALB 0.613(0.531~0.692) 30.62 g/L 37.10 47.73 -0.151 7
    LAR 0.843(0.775~0.897) 14.21 75.81 79.55 0.553 6
    单核细胞 0.588(0.505~0.668) 2.03×109/L 37.10 42.05 -0.208 5
    淋巴细胞 0.564(0.481~0.645) 2.01×109/L 40.32 45.45 -0.142 3
    MLR 0.818(0.747~0.876) 1.06 79.03 81.82 0.608 5
    联合 0.920(0.864~0.958) - 96.77 87.50 0.842 7
    下载: 导出CSV
  • [1]

    Lupu L, Palmer A, Huber-Lang M. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma-and SARS-CoV-2-Induced ARDS[J]. Front Immunol, 2020, 11: 584514. doi: 10.3389/fimmu.2020.584514

    [2]

    Spadaro S, Park M, Turrini C, et al. Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine[J]. J Inflamm(Lond), 2019, 16: 1. doi: 10.1186/s12950-018-0202-y

    [3]

    孔程祥, 李莉, 金萍, 等. 血清白蛋白、乳酸脱氢酶及乳酸脱氢酶/白蛋白比值检测在儿童急性呼吸窘迫综合征诊治中的临床意义[J]. 中国实用医药, 2020, 15(15): 19-21. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSSA202015007.htm

    [4]

    王梦瑶, 张薇, 郭友芳, 等. 单核细胞/淋巴细胞比值与呼吸系统疾病评估相关性的研究进展[J]. 医学综述, 2021, 27(15): 3045-3049. doi: 10.3969/j.issn.1006-2084.2021.15.025

    [5]

    ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition[J]. JAMA, 2012, 307(23): 2526-2533.

    [6]

    Hancock A. Parkinsonism together with the "APACHE type" in encephalitis lethargica[J]. Br Med J, 1925, 1(3360): 966. doi: 10.1136/bmj.1.3360.966

    [7]

    Vincent JL, Moreno R, Takala J, et al. The SOFA(Sepsis-related Organ Failure Assessment)score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22(7): 707-710. doi: 10.1007/BF01709751

    [8]

    Cheng Q, Lai X, Yang L, et al. Serum CD5 L predicts acute lung parenchymal injury and acute respiratory distress syndrome in trauma patients[J]. Medicine(Baltimore), 2021, 100(39): e27219.

    [9]

    Yang L, Gao C, Li F, et al. Monocyte-to-lymphocyte ratio is associated with 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study[J]. J Intensive Care, 2021, 9(1): 49. doi: 10.1186/s40560-021-00564-6

    [10]

    Ding J, Karp JE, Emadi A. Elevated lactate dehydrogenase(LDH)can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments[J]. Cancer Biomark, 2017, 19(4): 353-363. doi: 10.3233/CBM-160336

    [11]

    Kuang ZS, Yang YL, Wei W, et al. Clinical characteristics and prognosis of community-acquired pneumonia in autoimmune disease-induced immunocompromised host: A retrospective observational study[J]. World J Emerg Med, 2020, 11(3): 145-151. doi: 10.5847/wjem.j.1920-8642.2020.03.003

    [12]

    Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China[J]. JAMA Intern Med, 2020, 180(7): 934-943. doi: 10.1001/jamainternmed.2020.0994

    [13]

    Godinez-Vidal AR, Correa-Montoya A, Enríquez-Santos D, et al. Is albumin a predictor of severity and mortality in patients with abdominal sepsis?[J]. Cir Cir, 2019, 87(5): 485-489. http://doc.paperpass.com/foreign/rgArti20194989948.html

    [14]

    Yin M, Si L, Qin W, et al. Predictive Value of Serum Albumin Level for the Prognosis of Severe Sepsis Without Exogenous Human Albumin Administration: A Prospective Cohort Study[J]. J Intensive Care Med, 2018, 33(12): 687-694. doi: 10.1177/0885066616685300

    [15]

    Bou Chebl R, Jamali S, Sabra M, et al. Lactate/Albumin Ratio as a Predictor of In-Hospital Mortality in Septic Patients Presenting to the Emergency Department[J]. Front Med(Lausanne), 2020, 7: 550182.

    [16]

    Jeon SY, Ryu S, Oh SK, et al. Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care[J]. Medicine(Baltimore), 2021, 100(41): e27538.

    [17]

    Dang W, Tao Y, Xu X, et al. The role of lung macrophages in acute respiratory distress syndrome[J]. Inflamm Res, 2022, 71(12): 1417-1432. doi: 10.1007/s00011-022-01645-4

    [18]

    Zhang Y, Zhang S. Prognostic value of glucose-to-lymphocyte ratio in critically ill patients with acute respiratory distress syndrome: A retrospective cohort study[J]. J Clin Lab Anal, 2022, 36(5): e24397.

    [19]

    Song C, Li H, Li Y, et al. NETs promote ALI/ARDS inflammation by regulating alveolar macrophage polarization[J]. Exp Cell Res, 2019, 382(2): 111486. doi: 10.1016/j.yexcr.2019.06.031

    [20]

    Zhang S, Chu C, Wu Z, et al. IFIH1 Contributes to M1 Macrophage Polarization in ARDS[J]. Front Immunol, 2020, 11: 580838.

  • 加载中

(1)

(4)

计量
  • 文章访问数:  356
  • PDF下载数:  200
  • 施引文献:  0
出版历程
收稿日期:  2023-07-24
刊出日期:  2023-10-10

目录